Case Report
BibTex RIS Cite

A case of penicillin resistant pneumococcal meningitis who developed red neck syndrom due to vancomycin therapy

Year 2019, , 34 - 37, 25.01.2019
https://doi.org/10.32322/jhsm.471102

Abstract

Red neck syndrome which is a
side effect of vancomycin, is associated with excessive release of histamine and
is sometimes a life threatening complication. In patients
who develop
red
neck syndrome, if necessary, vancomycin therapy may be continued with
corticosteroids and antihistamines or an alternative antibiotic may be started.
In this report, a 54 year-old female patient who was
started vancomycin therapy because of penicillin resistant pneumococcal
meningitis and developed red neck syndrome on 8th day of the therapy was
presented. It was learned that the patient's vancomycin infusion that morning
was shorter than one hour. Vancomycin therapy was stopped and intravenous
linezolide was started. In conclusion, red neck syndrome may develop due to rapid
infusion of vancomycin. In this patients linezolide may be used as alternative
therapy. 

References

  • 1. Ulusoy S. Dirençli pnömokok infeksiyonlarında antimikrobiyal ilaç seçimi. Flora 2003; 8: 22-6.
  • 2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 20thInformational Supplement, 2010, M100-S20. CLSI, Wayne, PA.
  • 3. Edward N. Janoff and Daniel M. Musher. Streptococcus pneumoniae. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th Edition, 2015; 201: 2310-27.e5.
  • 4. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice Guidelines for the Management of Bacterial Meningitis. Clinical Infectious Diseases 2004; 39: 1267-84.
  • 5. Martel TJ, Whitten RA. Red Man Syndrome. Treasure Island (FL): Stat Pearls Publishing; 2018-.www.ncbi.nlm.nih.gov/pubmed/29494112.
  • 6. Sivagnanam S and Deleu D. Red man syndrome. Crit Care 2003; 7: 119-20.
  • 7. Polk RE, Healy DP, Schwartz LB, Rock DT, Garson ML, Roller K. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis 1988; 157: 502-7.
  • 8. Cheung RP, DiPiro JT. Vancomycin: an update. Pharmacotherapy 1986; 6: 153-69.
  • 9. Levy M, Koren G, Dupuis L, Read SE. Vancomycin-induced red man syndrome. Pediatrics 1990; 86: 572-80.
  • 10. Atalan N, Fazlıoğulları O, Akgün S. Kırmızı adam (red man) sendromu. GKDA Derg 2013; 19: 106-8.
  • 11. Polk RE. Anaphylactoid reactions to glycopeptide antibiotics. J Antimicrob Chemother 1991; 27 Suppl B: 17-29.
  • 12. Lin SK, Mulieri KM, Ishmael FT. Characterization of vancomycin reactions and inezolid utilization in the pediatric population. J Allergy Clin Immunol Pract 2017; 5: 750-6.

Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu

Year 2019, , 34 - 37, 25.01.2019
https://doi.org/10.32322/jhsm.471102

Abstract

Vankomisine bağlı olarak gelişen yan etkilerden
red neck (kırmızı boyun) sendromu histamin aşırı salınımına bağlı bazen hayatı
tehdit edebilen bir komplikasyondur. Red neck sendromu gelişen hastalarda zorunlu
hallerde kortikosterod ve antihistaminiklerle birlikte vankomisin tedavisine
devam edilebilir veya alternatif bir antibiyotik tedavisine geçilebilir. Bu
yazıda, penisiline dirençli pnömokok menenjiti tanısıyla vankomisin tedavisi
başlanan ve tedavinin 8. gününde red neck sendromu gelişen 54 yaşında bir kadın
hasta sunuldu. Hastanın o sabah verilen vankomisin infüzyonunun bir saatten kısa
sürdüğü öğrenildi.  Hastanın vankomisin
tedavisi kesilerek intravenöz linezolid tedavisine geçildi.



Sonuç olarak, vankomisinin hızlı infüzyonuna bağlı olarak red neck
sendromu gelişebilir ve bu olgularda tedavi yönetiminde alternatif ilaç olarak
linezolid kullanılabilir. 

References

  • 1. Ulusoy S. Dirençli pnömokok infeksiyonlarında antimikrobiyal ilaç seçimi. Flora 2003; 8: 22-6.
  • 2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 20thInformational Supplement, 2010, M100-S20. CLSI, Wayne, PA.
  • 3. Edward N. Janoff and Daniel M. Musher. Streptococcus pneumoniae. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th Edition, 2015; 201: 2310-27.e5.
  • 4. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice Guidelines for the Management of Bacterial Meningitis. Clinical Infectious Diseases 2004; 39: 1267-84.
  • 5. Martel TJ, Whitten RA. Red Man Syndrome. Treasure Island (FL): Stat Pearls Publishing; 2018-.www.ncbi.nlm.nih.gov/pubmed/29494112.
  • 6. Sivagnanam S and Deleu D. Red man syndrome. Crit Care 2003; 7: 119-20.
  • 7. Polk RE, Healy DP, Schwartz LB, Rock DT, Garson ML, Roller K. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis 1988; 157: 502-7.
  • 8. Cheung RP, DiPiro JT. Vancomycin: an update. Pharmacotherapy 1986; 6: 153-69.
  • 9. Levy M, Koren G, Dupuis L, Read SE. Vancomycin-induced red man syndrome. Pediatrics 1990; 86: 572-80.
  • 10. Atalan N, Fazlıoğulları O, Akgün S. Kırmızı adam (red man) sendromu. GKDA Derg 2013; 19: 106-8.
  • 11. Polk RE. Anaphylactoid reactions to glycopeptide antibiotics. J Antimicrob Chemother 1991; 27 Suppl B: 17-29.
  • 12. Lin SK, Mulieri KM, Ishmael FT. Characterization of vancomycin reactions and inezolid utilization in the pediatric population. J Allergy Clin Immunol Pract 2017; 5: 750-6.
There are 12 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Case Report
Authors

Hüseyin Esmer This is me

Salih Cesur

Çiğdem Ataman Hatipoğlu This is me

Esra Kaya Kılıç This is me

Sami Kınıklı This is me

Güler Vahaboğlu This is me

Publication Date January 25, 2019
Published in Issue Year 2019

Cite

AMA Esmer H, Cesur S, Ataman Hatipoğlu Ç, Kaya Kılıç E, Kınıklı S, Vahaboğlu G. Vankomisin tedavisine bağlı olarak red neck sendromu gelişen penisiline dirençli pnömokok menenjiti olgusu. J Health Sci Med / JHSM. January 2019;2(1):34-37. doi:10.32322/jhsm.471102

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Editor List for 2022

Assoc. Prof. Alpaslan TANOĞLU (MD)  

Prof. Aydın ÇİFCİ (MD)

Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)

Prof. Murat KEKİLLİ (MD)

Prof. Yavuz BEYAZIT (MD) 

Prof. Ekrem ÜNAL (MD)

Prof. Ahmet EKEN (MD)

Assoc. Prof. Ercan YUVANÇ (MD)

Assoc. Prof. Bekir UÇAN (MD) 

Assoc. Prof. Mehmet Sinan DAL (MD)


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.